Patent details

Basic Information

Publication number:

EP3286562

PCT Application Number:

EP2016059196

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP167225481

PCT Publication Number:

WO2016170187

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

BIOMARKERS FOR DETERMINING THE CLINICAL RESPONSE TO CELL THERAPY

French Title of Invention:

BIOMARQUEURS POUR DÉTERMINER LA RÉPONSE CLINIQUE À UNE THÉRAPIE CELLULAIRE

German Title of Invention:

BIOMARKER ZUR BESTIMMUNG DER KLINISCHEN REAKTION AUF ZELLTHERAPIE

SPC Number:

Dates

Filing date:

25/04/2016

Grant date:

12/08/2020

EP Publication Date:

28/02/2018

PCT Publication Date:

27/10/2016

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/08/2020

EP B1 Publication Date:

12/08/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

25/04/2021

Expiration date:

25/04/2036

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/08/2020

 

 

Name:

TiGenix, S.A.U.

Address:

Parque Tecnológico de Madrid C/ Marconi, 1, 28760 Tres Cantos (Madrid), Spain (ES)

Inventor

1

Name:

DALEMANS, Wilfried

Address:

Spain (ES)

2

Name:

DE LA ROSA, Olga

Address:

Spain (ES)

Priority

Priority Number:

15382206

Priority Date:

24/04/2015

Priority Country:

European Patent Office (EPO) (EP)

Classification

IPC classification:

G01N 33/50; A61K 35/28;

Publication

European Patent Bulletin

Issue number:

202033

Publication date:

12/08/2020

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages